| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | Dec 11, 2025 | GENELUX Corp | Chief Technical Officer | Sell | 26.3 | -3,706 | -2.32% | ✗ | $14.4K |
| May 12, 2025 | May 13, 2025 | GENELUX Corp | VP, Pharmaceutical Development | Sell | 26.3 | -4,737 | -8.31% | ✗ | $13.8K |
| Dec 16, 2024 | Dec 18, 2024 | GENELUX Corp | VP, Pharmaceutical Development | Sell | 26.3 | -6,300 | -30.07% | ✗ | $14.7K |
| Aug 18, 2023 | Aug 22, 2023 | GENELUX Corp | VP, Pharmaceutical Development | Sell | 22.5 | -3,265 | -36.28% | ✗ | $77.5K |